Citations

Citations to this article as recorded by  

• How Indian Pharma Industry Performed in the Last Decade? Impact of a Non-macroeconomic Variable and Financial Distress
  Pooja Singh, Anindita Chakraborty
  Jindal Journal of Business Research.2023; 12(2): 143.     CrossRef
• How structural changes are driving R&D activity in India’s pharmaceutical sector
  Niloufer Sohrabji, Kristen Marquette
  Journal of Pharmaceutical Health Services Research.2023; 14(3): 256.     CrossRef
• Patent and Marketing Exclusivities 101 for Drug Developers
  Bryan Oronsky, Scott Caroen, Franck Brinkhaus, Tony Reid, Meaghan Stirn, Raj Kumar
  Recent Patents on Biotechnology.2023; 17(3): 257.     CrossRef
• The driving process of technological innovation in construction: a firm-level CDM analysis
  Zheng Gong, Nannan Wang
  Construction Innovation .2022; 22(2): 222.     CrossRef
• Envisioning the challenges of the pharmaceutical sector in the Indian health-care industry: a scenario analysis
  Giuseppe Festa, Ashutosh Kolte, Maria Rosaria Carli, Matteo Rossi
  Journal of Business & Industrial Marketing.2022; 37(8): 1662.     CrossRef
• Can the Profitability of Medical Enterprises Be Improved After Joining China's Centralized Drug Procurement? A Difference-in-Difference Design
  Yu-Fei Hua, Jin Lu, Bing Bai, Han-Qing Zhao
  Frontiers in Public Health.2022;[Epub]     CrossRef
• Ambidexterity's influence on export strategy development—The case of the Indian pharmaceutical industry
  Ashutosh Kolte, Giuseppe Festa, Matteo Rossi, Alkis Thrassou, Demetris Vrontis, Michael Christofi
  Thunderbird International Business Review.2022; 64(5): 465.     CrossRef
• Local pharmaceutical research and development capacity in a developing country: a qualitative exploration of perspectives from key stakeholders in Ethiopia
  Muluken Nigatu Selam, Samuel Abera, Helen Geremew, Eskinder Eshetu Ali
  Journal of Pharmaceutical Policy and Practice.2022;[Epub]     CrossRef
• Optimization and Quest of HPMC loaded Stavudine Controlled Release Dosage Development by Central Composite Design utilizing Reduced Factorial Screening Technique
  Jyothsna Gangolu, Sandyapakula Balaiah, Sisir Nandi, Harekrishna Roy
  Brazilian Journal of Pharmaceutical Sciences.2022;[Epub]     CrossRef
• The contribution of intellectual capital to financial stability in Indian pharmaceutical companies
  Giuseppe Festa, Matteo Rossi, Ashutosh Kolte, Luca Marinelli
  Journal of Intellectual Capital.2021; 22(2): 337.     CrossRef
• Factors affecting profitability of pharmaceutical company: an Indonesian evidence
  Harianto Lim, Rofikoh Rokhim
  Journal of Economic Studies.2021; 48(5): 981.     CrossRef
• Impact of Monetary Policy Uncertainty on R&D Investment Smoothing Behavior of Pharmaceutical Manufacturing Enterprises: Empirical Research Based on a Threshold Regression Model
  Jingyuan Yang, Ling Wang, Ziyuan Sun, Fangming Zhu, Yihui Guo, Yan Shen
  International Journal of Environmental Research an.2021; 18(21): 11560.     CrossRef
• Drivers of ICT investments in bakery and sugar confectionery processed food sub-sector in India
  Navyashree GR, Savita Bhat
  Journal of Agribusiness in Developing and Emerging.2020; 10(2): 191.     CrossRef
• Gouvernance et intensité d’innovation dans les ETI innovantes
  Léopold Djoutsa Wamba, Éric Braune, Frédéric Teulon
  Management & Avenir.2020; N° 118(4): 111.     CrossRef
• MALİYET YAPIŞKANLIĞININ YENİDEN GÖZDEN GEÇİRİLMESİ: BORSA İSTANBUL İMALAT SANAYİ ÖRNEĞİ
  Mehmet Emin KARABAYIR
  Muhasebe ve Vergi Uygulamaları Dergisi.2019; 12(2): 317.     CrossRef
• Bioaugmentation effect of Aeromonas hydrophila and Pseudomonas putida on kinetics of activated sludge process in treating pharmaceutical industrial wastewater
  Marija Vuković Domanovac, Monika Šabić Runjavec, Ernest Meštrović
  Journal of Chemical Technology & Biotechnology.2019; 94(8): 2721.     CrossRef
• Replicating the R&D investments and financial structure relationship: evidence from Borsa İstanbul
  Nasif Ozkan
  Management Review Quarterly.2018; 68(4): 399.     CrossRef
• Firm level R&D intensity: evidence from Indian drugs and pharmaceutical industry
  Shilpi Tyagi, D. K. Nauriyal, Rachita Gulati
  Review of Managerial Science.2018; 12(1): 167.     CrossRef
• Impact of investment in intangible assets on corporate performance in India
  Aparna Bhatia, Khushboo Aggarwal
  International Journal of Law and Management.2018; 60(5): 1058.     CrossRef
• Relation of R&D expense to turnover and number of listed companies in all industrial fields
  Jun-Hwan Park, Bangrae Lee, Yeong-Ho Moon, GyuSeok Kim, Lee-Nam Kwon
  Journal of Open Innovation: Technology, Market, an.2018; 4(1): 1.     CrossRef
• Policy to encourage the development of antimicrobials
  Ayman Chit, Paul Grootendorst
  International Journal of Health Governance.2018; 23(2): 101.     CrossRef
• O IMPACTO DOS INVESTIMENTOS EM P&D NO DESEMPENHO DAS EMPRESAS: APLICAÇÕES NO USO DE REGRESSÃO QUANTÍLICA COM VARIÁVEIS INSTRUMENTAIS
  Leonardo Andrade Rocha, Ahmad Saeed Khan, Patrícia Verônica Pinheiro Sales Lima, Maria Ester Soares Dal Poz, Carlos Alano Soares de Almeida
  Revista de Economia Contemporânea.2018;[Epub]     CrossRef